CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 5, 2008
Clin J Am Soc Nephrol 4: 168-177, 2009
© 2009 American Society of Nephrology
doi: 10.2215/CJN.00810208

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.00810208v1
4/1/168    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hothi, D. K.
Right arrow Articles by Winyard, P. J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hothi, D. K.
Right arrow Articles by Winyard, P. J. D.

Epidemiology and Outcomes

Mild Fetal Renal Pelvis Dilatation—Much Ado About Nothing?

Daljit K. Hothi*, Angie S. Wade{dagger}, Ruth Gilbert{ddagger}, and Paul J. D. Winyard*

* Nephro-Urology Unit, {dagger} Centre for Paediatric Epidemiology and Biostatistics, and {ddagger} Centre for Evidence-Based Child Health, University College London Institute of Child Health, London, United Kingdom

Correspondence: Paul Winyard, Nephro-Urology Unit, Institute of Child Health, UCL, 30 Guilford Street, London, WC1N 1EH, United Kingdom, Phone: 020 7905 2116; Fax: 020 7905 2133; E-mail: pwinyard{at}ich.ucl.ac.uk

Background: Renal pelvis dilatation (RPD) occurs in 1% of fetuses. Severe RPD (>15 mm) is frequently associated with urinary tract pathology. For the majority with mild (5 to 9 mm) to moderate (10 to 15 mm) RPD, however, there is uncertainty about the risk of abnormalities and how much postnatal investigation is required.

Study design: Systematic review of cohort studies of fetuses with RPD ≤ 15 mm and metaregression to estimate risks of postnatal RPD, obstruction, and VUR.

Results: Of 506 potentially relevant papers, 18 met the inclusion criteria. Risk of postnatal RPD increased with fetal RP size and earlier gestation. Odds ratios for postnatal RPD doubled per millimeter increase in fetal RP size: At 20 wk gestation, for example, 18% of fetuses with mean RP of 6 mm were estimated to have persistent postnatal RPD, compared with 95% of fetuses with 12 mm RPD, but risks were decreased by 16% to 18% per week of presentation gestation. Estimated risks of obstruction and VUR were substantially lower, particularly in the mild group such as the 6 mm example above: obstruction 2%, VUR 4%.

Conclusions: Our novel risk estimates are useful for antenatal counseling at presentation. The low frequency of obstruction/VUR in mild RPD raises questions over the most appropriate investigation of these cases but further data are required before establishing definitive postnatal management pathways. We suggest the need for a large prospective multicenter study to collect individual patient parameters/results and search for additional prognostic indicators.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Nephrology.